Zobrazeno 1 - 10
of 11
pro vyhledávání: '"N Iu, Lashch"'
Autor:
E V, Popova, A N, Boĭko, M V, Davydovskaia, T L, Demina, T M, Kukel', N Iu, Lashch, N F, Popova, N V, Khachanova, S G, Shchur, E I, Gusev
Publikováno v:
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 113(10 Pt 2)
We summarized the 1-year experience of using the Russian Β-interferon-1b biosimilar (infibeta) in 123 patients including 65 patients with relapsing-remitting multiple sclerosis (RMS) and 58 patients with secondary progressive multiple sclerosis (SPM
Autor:
E A, Sokolova, N A, Malkova, D S, Korobko, A S, Rozhdestvenskiĭ, A V, Kakulia, E V, Khanokh, R A, Delov, F A, Platonov, T E, Popova, E G, Aref'eva, N N, Zagorskaia, V M, Alifirova, M A, Titova, I V, Smagina, S A, El'chaninova, A V, Popovtseva, Iu N, Lichenko, M A, Dymova, A S, Vaĭner, O V, P'iankova, I P, Oskorbin, A A, Kechin, V P, Puzyrev, O G, Kulakova, E Iu, Tsareva, O O, Favorova, S G, Shur, N Iu, Lashch, N F, Popova, E I, Gusev, A N, Boĭko, Iu S, Aul'chenko, M L, Filipenko
Publikováno v:
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 113(2 Pt 2)
Multiple sclerosis is a classic multifactorial disease in which etiology interaction of external factors and structural features of a large number of genes plays an important role. Identifying risk factors for multiple sclerosis and creating an integ
Publikováno v:
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 112(9 Pt 2)
Clinical features and MRI-characteristics of two demyelinating diseases: acute disseminated encephalomyelitis (ADEM) and multiple sclerosis (MS) are discussed. Despite the seeming obviousness of differential-diagnostic criteria, the individual course
Autor:
E Iu, Tsareva, O G, Kulakova, O Iu, Makarycheva, A N, Boĭko, S G, Shchur, N Iu, Lashch, N F, Popova, E I, Gusev, V V, Bashinskaia, D V, L'vov, A V, Favorov, M F, Ochs, O O, Favorova
Publikováno v:
Molekuliarnaia biologiia. 45(6)
Complex association analysis of copaxone (glatiramer acetate) immunotherapy efficacy with allelic polymorphism in the number of immune response genes, which encode interferone beta (IFNB1), transforming growth factor beta1 (TGFB1), interferone gamma
Autor:
B T, Mugutdinova, A N, Boĭko, S V, Serkov, L M, Fadeeva, E V, Enikolopova, A N, Bogolepova, N Iu, Lashch, M F, Davydovskaia, N V, Khachanova, N F, Popova, S G, Shchur, O V, Riabukhina, A V, Romashkin, T V, Sidorenko, E I, Gusev
Publikováno v:
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 111(2 Pt 2)
A complex study of 50 patients with active typical remitting multiple sclerosis (MS) was carried out. Neuropsychological testing using Wechsler and Stroop tests and MRI of the brain with the morphometric analysis of focal and diffusive changes were u
Autor:
Iu A, Klimov, A N, Boĭko, N F, Popova, N Iu, Lashch, A V, Petrov, V V, Ovcharov, S N, Sharanova, O V, Riabukhina, E F, Krynkina, T T, Batysheva, A V, Romashkin
Publikováno v:
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 111(2 Pt 2)
Motor and coordination disorders are the most prominent clinical presentations of multiple sclerosis. Currently, good results were achieved in the pathogenetic treatment of the disease. However methods of treatment of motor and coordination disorders
Autor:
E V, Popova, A N, Boĭko, M F, Davydovskaia, T L, Demina, N Iu, Lashch, N F, Popova, N V, Khachanova, S G, Shchur, E I, Gusev
Publikováno v:
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 111(2 Pt 2)
We summarized the 3-year experience of using beta-interferon 1a (44 mcg, subcutaneously) in the form of the preparation rebif in 141 patients including 120 patients with active remitting multiple sclerosis (RMS) and 21 patients with secondary progres
Autor:
A N, Boĭko, M F, Davydovskaia, T L, Demina, N Iu, Lashch, V V, Ovcharov, N F, Popova, N I, Sinbukhova, N V, Khachanova, S G, Shchur, E I, Gusev
Publikováno v:
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova.
In last decades, practical neurologists are able to use DMT in multiple sclerosis (MS) in every day practice. This paper presents data of 3-year study of DMT (copaxone and betaferon) treatment of 280 patients with definite diagnosis of multiple scler
Publikováno v:
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. (Spec No 2)
146 patients with multiple sclerosis are treated by copaxone in the Moscow MS Centre. The relaps exacerbation rate decreased by 72%, the relapse rate reduced by 25.6% during the copaxone treatment. EDSS score did not increase both in group with and w
Publikováno v:
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. (Spec No 2)
Multiple sclerosis (MS) was believed to be an autoimmune disease of central nervous system (CNS). Recently, several studies showing early involvement of peripheral nervous system (PNS) in MS pathological process have been published. This review own a